Flatiron Health, Inc.

FDA Regulatory Profile

Flatiron Health, Inc. has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record.

Latest inspection
Nov 8, 2018 · NAI

Newer recall under related name Foundation Medicine: Jun 10, 2026, Z-2951-2026.

Reviewing Flatiron Health, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Flatiron Health, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 4, 2026 (checked Nov 8, 2026, unchanged)File dated Nov 3, 2026Current
510(k) clearances0Nov 8, 2026File dated Nov 2, 2026Current
Inspections1Nov 9, 2026Newest record Oct 28, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Related names

NameRecalls510(k)InspectionsComplianceMost recent recall
Foundation Medicine
Same company group
10080Jun 10, 2026 (Z-2951-2026)
Ventana Medical Systems
Same company group
4249140Apr 20, 2026 (Z-2913-2026)
Roche Diagnostics Operations
Same company group
127790Jan 20, 2026 (Z-1476-2026)
Genentech
Same company group
110450May 20, 2024 (D-0509-2024)
Roche Diabetes Care
Same company group
291320May 13, 2024 (Z-2174-2024)
Roche Molecular Systems
Same company group
4255260Dec 21, 2022 (Z-1106-2023)
Roche Diagnostics Corporation
Same company group
39600Jun 3, 2019 (Z-1979-2019)
Roche Diagnostics
Same company group
0457240—
Hoffmann La Roche
Same company group
0040—
Roche Pharma
Same company group
0030—
Roche
Same company group
0200—
Spark Therapeutics
Same company group
0020—

Recent FDA Inspections

DateSiteProductClassificationFEI
Nov 8, 2018New York, NYDrugsNo Action Indicated (NAI)3014696560

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.

FDA-Inspected Facilities

FacilityLocationInspectionsLatest
FEI 3014696560New York, NY1Nov 8, 2018

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.